Welcome to LookChem.com Sign In|Join Free
  • or
Enbucrilate is a bacteriostatic agent that is commonly used in the medical field for its painless application. It possesses adhesive properties, making it suitable for various applications in wound care and treatment of bleeding.

6606-65-1

Post Buying Request

6606-65-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

6606-65-1 Usage

Uses

Used in Medical Industry:
Enbucrilate is used as an adhesive for lacerations of the skin, providing a painless and effective means of wound closure. Its bacteriostatic properties help prevent infection and promote healing.
Enbucrilate is also used in the treatment of bleeding from vascular structures, thanks to its ability to form a stable adhesive bond that can effectively control bleeding and facilitate clot formation.

Check Digit Verification of cas no

The CAS Registry Mumber 6606-65-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,6,0 and 6 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 6606-65:
(6*6)+(5*6)+(4*0)+(3*6)+(2*6)+(1*5)=101
101 % 10 = 1
So 6606-65-1 is a valid CAS Registry Number.
InChI:InChI=1/C7H11NO/c1-2-3-4-7(9)5-6-8/h2-5H2,1H3

6606-65-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name Enbucrilate

1.2 Other means of identification

Product number -
Other names n-butyl 2-chloropropionate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:6606-65-1 SDS

6606-65-1Synthetic route

formaldehyd
50-00-0

formaldehyd

cyanoacetic acid butyl ester
5459-58-5

cyanoacetic acid butyl ester

n-butyl cyanoacrylate
6606-65-1

n-butyl cyanoacrylate

Conditions
ConditionsYield
Stage #1: formaldehyd; cyanoacetic acid butyl ester With 1,5,7-triazabicyclo[5.5.0]dec-5-ene; triphenylphosphine at 20 - 85℃; under 30 Torr; for 1h; Green chemistry;
Stage #2: With phosphorus pentoxide; hydroquinone at 20 - 220℃; under 3 Torr; for 1h; Reagent/catalyst; Green chemistry;
95.3%
Stage #1: formaldehyd; cyanoacetic acid butyl ester With piperidine; sodium hydrogencarbonate; sodium carbonate; sodium 4-dodecylbenzenesulfonate In water at 80 - 90℃; for 1h;
Stage #2: With phosphoric acid In water Reagent/catalyst;
81.3%
Stage #1: formaldehyd; cyanoacetic acid butyl ester With piperidine hydrochloride In toluene at 90 - 200℃; for 0.4h; Dean-Stark; Microwave irradiation;
Stage #2: With phosphorus pentoxide; toluene-4-sulfonic acid; hydroquinone In toluene at 200℃; under 17 Torr; for 0.25h; Microwave irradiation;
72%
With nitromethane In acetonitrile at 90℃; for 6.5h; Temperature; Knoevenagel Condensation;
Stage #1: formaldehyd; cyanoacetic acid butyl ester for 3h; Reflux;
Stage #2: Pyrolysis;
cyanoacetic acid butyl ester
5459-58-5

cyanoacetic acid butyl ester

n-butyl cyanoacrylate
6606-65-1

n-butyl cyanoacrylate

Conditions
ConditionsYield
With hydroquinone at 20℃; for 0.0833333h; Neat (no solvent);79%
di-n-butyloxymethane
2568-90-3

di-n-butyloxymethane

cyanoacetic acid butyl ester
5459-58-5

cyanoacetic acid butyl ester

n-butyl cyanoacrylate
6606-65-1

n-butyl cyanoacrylate

Conditions
ConditionsYield
With dodecylbenzenesulfonic acid piperidine salt at 125 - 127℃; Reagent/catalyst; Temperature;68%
diacetoxymethane
628-51-3

diacetoxymethane

cyanoacetic acid butyl ester
5459-58-5

cyanoacetic acid butyl ester

n-butyl cyanoacrylate
6606-65-1

n-butyl cyanoacrylate

Conditions
ConditionsYield
With piperazine; toluene-4-sulfonic acid at 120 - 130℃; for 1h; Reagent/catalyst; Time;
ethyl 2-cyanoacrylate
7085-85-0

ethyl 2-cyanoacrylate

butan-1-ol
71-36-3

butan-1-ol

n-butyl cyanoacrylate
6606-65-1

n-butyl cyanoacrylate

Conditions
ConditionsYield
With phosphoric acid; sulfuric acid; toluene-4-sulfonic acid; acetic acid; chloroacetic acid at 100 - 115℃; Reagent/catalyst; Temperature;440 g
ethyl 2-cyanoacetate
105-56-6

ethyl 2-cyanoacetate

n-butyl cyanoacrylate
6606-65-1

n-butyl cyanoacrylate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: tetrabutyl titanate / 3 h / Reflux
2.1: 3 h / Reflux
2.2: Pyrolysis
View Scheme
n-butyl cyanoacrylate
6606-65-1

n-butyl cyanoacrylate

ethyl 3-(butylamino)but-2-enoate
5065-81-6, 21759-72-8, 21759-73-9

ethyl 3-(butylamino)but-2-enoate

2-[1-Butylamino-eth-(E)-ylidene]-4-cyano-pentanedioic acid 5-butyl ester 1-ethyl ester
71188-28-8

2-[1-Butylamino-eth-(E)-ylidene]-4-cyano-pentanedioic acid 5-butyl ester 1-ethyl ester

Conditions
ConditionsYield
In benzene
n-butyl cyanoacrylate
6606-65-1

n-butyl cyanoacrylate

methyl 3-(benzylamino)but-2-enoate
72002-24-5, 36244-63-0

methyl 3-(benzylamino)but-2-enoate

2-[1-Benzylamino-eth-(E)-ylidene]-4-cyano-pentanedioic acid 5-butyl ester 1-methyl ester
71160-96-8

2-[1-Benzylamino-eth-(E)-ylidene]-4-cyano-pentanedioic acid 5-butyl ester 1-methyl ester

Conditions
ConditionsYield
In benzene
n-butyl cyanoacrylate
6606-65-1

n-butyl cyanoacrylate

benzyl 3-benzylaminobut-2-enoate
71161-03-0

benzyl 3-benzylaminobut-2-enoate

2-[1-Benzylamino-eth-(E)-ylidene]-4-cyano-pentanedioic acid 1-benzyl ester 5-butyl ester
71161-00-7

2-[1-Benzylamino-eth-(E)-ylidene]-4-cyano-pentanedioic acid 1-benzyl ester 5-butyl ester

Conditions
ConditionsYield
In benzene
n-butyl cyanoacrylate
6606-65-1

n-butyl cyanoacrylate

ethyl 3-(n-propylamino)but-2-enoate
5091-92-9

ethyl 3-(n-propylamino)but-2-enoate

2-Cyano-4-[1-propylamino-eth-(E)-ylidene]-pentanedioic acid 1-butyl ester 5-ethyl ester
71160-93-5

2-Cyano-4-[1-propylamino-eth-(E)-ylidene]-pentanedioic acid 1-butyl ester 5-ethyl ester

Conditions
ConditionsYield
In benzene
n-butyl cyanoacrylate
6606-65-1

n-butyl cyanoacrylate

ethyl aminocrotonate
626-34-6, 7318-00-5, 41867-20-3

ethyl aminocrotonate

2-[1-Amino-eth-(E)-ylidene]-4-cyano-pentanedioic acid 5-butyl ester 1-ethyl ester

2-[1-Amino-eth-(E)-ylidene]-4-cyano-pentanedioic acid 5-butyl ester 1-ethyl ester

Conditions
ConditionsYield
In benzene
n-butyl cyanoacrylate
6606-65-1

n-butyl cyanoacrylate

ethyl 3-methylaminocrotonate
870-85-9

ethyl 3-methylaminocrotonate

2-Cyano-4-[1-methylamino-eth-(E)-ylidene]-pentanedioic acid 1-butyl ester 5-ethyl ester

2-Cyano-4-[1-methylamino-eth-(E)-ylidene]-pentanedioic acid 1-butyl ester 5-ethyl ester

Conditions
ConditionsYield
In benzene
n-butyl cyanoacrylate
6606-65-1

n-butyl cyanoacrylate

ethyl 3-ethylamino-2-butenoate
13070-53-6

ethyl 3-ethylamino-2-butenoate

2-Cyano-4-[1-ethylamino-eth-(E)-ylidene]-pentanedioic acid 1-butyl ester 5-ethyl ester

2-Cyano-4-[1-ethylamino-eth-(E)-ylidene]-pentanedioic acid 1-butyl ester 5-ethyl ester

Conditions
ConditionsYield
In benzene
n-butyl cyanoacrylate
6606-65-1

n-butyl cyanoacrylate

ethyl 3-anilinocrotonate
6287-35-0

ethyl 3-anilinocrotonate

2-Cyano-4-[1-phenylamino-eth-(E)-ylidene]-pentanedioic acid 1-butyl ester 5-ethyl ester
71161-02-9

2-Cyano-4-[1-phenylamino-eth-(E)-ylidene]-pentanedioic acid 1-butyl ester 5-ethyl ester

Conditions
ConditionsYield
In benzene
n-butyl cyanoacrylate
6606-65-1

n-butyl cyanoacrylate

ethyl 3-(benzylamino)crotonate
1020-67-3

ethyl 3-(benzylamino)crotonate

2-[1-Benzylamino-eth-(E)-ylidene]-4-cyano-pentanedioic acid 5-butyl ester 1-ethyl ester
71160-98-0

2-[1-Benzylamino-eth-(E)-ylidene]-4-cyano-pentanedioic acid 5-butyl ester 1-ethyl ester

Conditions
ConditionsYield
In benzene
n-butyl cyanoacrylate
6606-65-1

n-butyl cyanoacrylate

benzyl-β-aminocrotonate
43107-11-5

benzyl-β-aminocrotonate

2-[1-Amino-eth-(E)-ylidene]-4-cyano-pentanedioic acid 1-benzyl ester 5-butyl ester

2-[1-Amino-eth-(E)-ylidene]-4-cyano-pentanedioic acid 1-benzyl ester 5-butyl ester

Conditions
ConditionsYield
In benzene
n-butyl cyanoacrylate
6606-65-1

n-butyl cyanoacrylate

methyl 3-aminocrotonate
14205-39-1

methyl 3-aminocrotonate

2-[1-Amino-eth-(E)-ylidene]-4-cyano-pentanedioic acid 5-butyl ester 1-methyl ester

2-[1-Amino-eth-(E)-ylidene]-4-cyano-pentanedioic acid 5-butyl ester 1-methyl ester

Conditions
ConditionsYield
In benzene
n-butyl cyanoacrylate
6606-65-1

n-butyl cyanoacrylate

polybutylcyanoacrylate, nanoparticles: size 290.4, polydispersity index 0.015; Monomer(s): butylcyanoacrylate

polybutylcyanoacrylate, nanoparticles: size 290.4, polydispersity index 0.015; Monomer(s): butylcyanoacrylate

Conditions
ConditionsYield
With D-glucose; citric acid; dextran pH=3;
n-butyl cyanoacrylate
6606-65-1

n-butyl cyanoacrylate

poly(n-butyl cyanoacrylate), anionic emulsion polymerization; monomer(s): n-butyl cyanoacrylate

poly(n-butyl cyanoacrylate), anionic emulsion polymerization; monomer(s): n-butyl cyanoacrylate

Conditions
ConditionsYield
With dodecylbenzene-sulphonic acid In water at 25℃; pH=2;
n-butyl cyanoacrylate
6606-65-1

n-butyl cyanoacrylate

dextran, Mw = 71 kDa

dextran, Mw = 71 kDa

poly(n-butyl 2-cyanoacrylate)-dextran block copolymer

poly(n-butyl 2-cyanoacrylate)-dextran block copolymer

Conditions
ConditionsYield
With ammonium cerium(IV) nitrate; nitric acid at 40℃; pH=1;
n-butyl cyanoacrylate
6606-65-1

n-butyl cyanoacrylate

poly(methyl methacrylate)

poly(methyl methacrylate)

poly(methyl methacrylate); poly(n-butyl cyanoacrylate); mixture of

poly(methyl methacrylate); poly(n-butyl cyanoacrylate); mixture of

Conditions
ConditionsYield
With sulfur dioxide; hydroquinone at 20℃;
n-butyl cyanoacrylate
6606-65-1

n-butyl cyanoacrylate

Reaxys ID: 15739938

Reaxys ID: 15739938

Conditions
ConditionsYield
With hydrogenchloride; sodium hydroxide; sodium dodecyl-sulfate; polysorbate 80 In Hexadecane; water at 0℃; for 0.116667h; pH=7; Product distribution / selectivity; ultrasonication;
With hydrogenchloride; sodium hydroxide; sodium dodecyl-sulfate In Hexadecane; water at 0℃; for 0.116667h; pH=7; ultrasonication;
2-octyl α-cyanoacrylate

2-octyl α-cyanoacrylate

n-butyl cyanoacrylate
6606-65-1

n-butyl cyanoacrylate

poly[(n-butyl cyanoacrylate)-co-(2-octyl cyanoacrylate)]

poly[(n-butyl cyanoacrylate)-co-(2-octyl cyanoacrylate)]

Conditions
ConditionsYield
With hydrogenchloride; poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) In water at 25℃; for 18h;
n-butyl cyanoacrylate
6606-65-1

n-butyl cyanoacrylate

poly(n-butyl cyanoacrylate)

poly(n-butyl cyanoacrylate)

Conditions
ConditionsYield
at 60℃; for 5h;
With hydrogenchloride; dextran 70 In water for 4h;
n-butyl cyanoacrylate
6606-65-1

n-butyl cyanoacrylate

doxorubicin hydrochloride
25316-40-9

doxorubicin hydrochloride

doxorubicin nanoparticles

doxorubicin nanoparticles

Conditions
ConditionsYield
Stage #1: n-butyl cyanoacrylate With hydrogenchloride; dextran 70 In water for 0.666667h;
Stage #2: doxorubicin hydrochloride In water for 4h;
n-butyl cyanoacrylate
6606-65-1

n-butyl cyanoacrylate

poly(butylcyanoacrylate) nanoparticles

poly(butylcyanoacrylate) nanoparticles

Conditions
ConditionsYield
With hydrogenchloride; fluoresceine isothiocyanate-dextran 70.000; dextran 70 In water at 20℃; for 4h;
formaldehyd
50-00-0

formaldehyd

n-butyl cyanoacrylate
6606-65-1

n-butyl cyanoacrylate

1,4-diammoniocyclohexane di-p-toluenesulfonate
16115-57-4

1,4-diammoniocyclohexane di-p-toluenesulfonate

Conditions
ConditionsYield
With acetic anhydride at 120 - 130℃; for 2h; Reagent/catalyst;

6606-65-1Relevant academic research and scientific papers

N-butyl cyanoacrylate synthesis. A new quality step using microwaves

Carriles, Yaquelin Ramos,Brito, Ruben Alvarez,Sanchez, Ricardo Martinez,Acevedo, Elayma Sanchez,Dominguez, Paola Rodriguez,Mueller, Wolf-Dieter

, p. 6220 - 6227 (2014)

Alkyl cyanoacrylates are interesting products for use in industry because of their properties enabling them to stick together a wide range of substrates. n-Butyl cyanoacrylate is one of the most successfully used tissue adhesives in the field of medicine because it exhibits bacteriostatic and haemostatic characteristics, in addition to its adhesive properties. At present, its synthesis is performed with good yields via Knoevenagel condensation using conventional sources of heating, but this requires a long processing time. The aim of this work was to look for a new way of synthesising n-butyl cyanoacrylate using microwave irradiation as the source of heating. This non-conventional source of heating most likely reduces the process time of the synthesis. In comparison with a conventional heating source, such as an oil bath, the results showed the advantages of this method whereby the n-butyl cyanoacrylate gave the same yield and quality with a reduction in the reaction time by a factor of 3-5-fold.

A novel cyanoacrylate-based matrix excipient in HPMCP capsules forms a sustained intestinal delivery system for orally administered drugs with enhanced absorption efficiency

Song, Liya,Chen, Pengfei,Yu, Jin,Han, Xiaolu,Hua, Yabing,Liu, Shan,Pang, Bo,Gao, Jing,Ma, Jiahua,Xu, Liang

, p. 1288 - 1296 (2021/02/21)

Patients prefer oral drug delivery due to its convenience and noninvasiveness. Nevertheless, a multitude of potentially clinically important drugs will not reach the market or achieve their full potential, due to their low bioavailability and instability in gastric acid. In this study, a novel oral drug delivery system based on poly-cyanoacrylate [a polymer of 2-(2-methoxyethoxy)ethyl-2-cyanoacrylate (MECA)] and hydroxypropyl methylcellulose phthalate (HPMCP) was developed and shown to permit intestinal targeting and sustained drug release. Aspirin [acetylsalicylic acid (ASA)] was selected as a model drug for atherosclerosis treatment. It was physically dissolved in liquid MECA, and the ASA-MECA matrix was then polymerized into a solid drug-loading depot in an HPMCP shell. The delivery of the drug depot in the intestine was achieved with the HPMCP shell; then the polymerized MECA (polyMECA) provided sustained drug release. The polyMECA excipient was not absorbed by the intestine due to its high molecular weight; a fluorescein-labeled assay indicated that it was excreted completely in feces after drug release. The formulation, ASA-polyMECA-HPMCP, showed good intestinal targeting and sustained drug releasein vitroandin vivo. Pharmacokinetic studies indicated that this formulation improved the bioavailability of ASA relative to commercially available controls. ASA-polyMECA-HPMCP showed desirable anti-atherosclerosis efficacy in a rabbit model, with significant enhancement of atheromatous lesion stability. Biosafety tests proved the low toxicity of ASA-polyMECA-HPMCP and the polyMECA matrix. We believe that this work has provided a practical and biocompatible system for sustained intestinal drug delivery that can be applied broadly with various drugs for specific therapeutic aims.

Synthesis process of alpha-n-butyl cyanoacrylate

-

Paragraph 0028-0032, (2020/06/09)

The invention provides a synthesis process of alpha-n-butyl cyanoacrylate. The synthesis process comprises the following steps: reacting formaldehyde and n-butyl cyanoacetate under the action of a catalyst and a catalyst assistant to obtain a wet prepolymer; and sequentially carrying out cracking and refining on the wet prepolymer to obtain the alpha-n-butyl cyanoacrylate. By adopting the synergistic effect of a composite additive and a dispersing agent, reaction time is greatly shortened, yield is obviously increased, an oil phase and a water phase are fully mixed under the condition of no solvent reaction, interface contact is expanded, product quality is improved, product purity is greater than or equal to 99.5%, and product yield is greater than or equal to 75%.

Preparation method of alpha-cyanoacrylate

-

Paragraph 0061; 0062; 0063; 0064; 0065; 0066; 0067-0085, (2019/06/11)

The invention relates to a preparation method of alpha-cyanoacrylate. The preparation method mainly includes the following steps that methyl cyanoacetate or ethyl cyanoacetate and formaldehyde are subjected to a condensation reaction to obtain a cyanoacrylate prepolymer; the cyanoacrylate prepolymer is cracked and rectified to obtain a methyl cyanoacrylate monomer or an ethyl cyanoacrylate monomer; and an anionic polymerization inhibitor, a free radical polymerization inhibitor, a catalyst and alcohol are added to the methyl cyanoacrylate monomer or the ethyl cyanoacrylate monomer for an esterexchange reaction, and the alpha-cyanoacrylate is obtained. According to the preparation method of the alpha-cyanoacrylate, the long-chain alpha-cyanoacrylate with the high content can be directly prepared, the depolymerization process under high-temperature and high-vacuum conditions is not required, the cost is lowered, the yield of products is increased, and the purity and stability of the products are improved.

Method for preparing glue and medical glue

-

Paragraph 0082-0085; 0097; 0098, (2018/06/26)

The present invention provides a method for preparing an acrylate based adhesive in high purity, which performs a process of producing an alkyl cyanoacrylate polymer from alkyl cyanoacetate and a process of depolymerizing the alkyl cyanoacrylate polymer into monomers together to reduce the production costs.(AA) Mix alkyl alcohol with an organic solvent(BB) Add cyanoacetic acid and strong acid to the mixed solution and heating the same for esterification(CC) Remove water produced during the esterification reaction by azeotropic distillation and purify/dry the mixture(DD) Stir alkyl cyanoacetate, a crosslinking agent, and a catalyst to prepare a polymer(EE) Prepare a crude polymer from the polymer(FF) Perform catalytic depolymerization of the crude polymer to obtain a monomer-type high purity polymerCOPYRIGHT KIPO 2018

Synthesis method of alpha-cyanoacrylate

-

Paragraph 0038-0043; 0046-0051, (2018/05/16)

The invention provides a preparation method of alpha-cyanoacrylate. The method comprises steps as follows: alpha-cyanoacetate and paraformaldehyde or a formaldehyde water solution are subjected to a condensation reaction through programmed temperature and sufficient stirring under the condition of reduced pressure in the presence of a catalyst; water is removed after the condensation reaction ends, a polymerization inhibitor is added for distillation cracking after sufficient dewatering, sufficient stirring, vacuum pumping and temperature increasing are performed, and a cracking reaction is performed. A crude monomer obtained through the steps is rectified, and a refined alpha-cyanoacrylate monomer with higher yield and purity can be obtained. The polycondensation catalyst is a compound catalyst of triphenylphosphine and a guanidine catalyst. The method is high in efficiency and safety, has low side reactions and is environmentally friendly, and the product yield and the product purityare high.

PROCESS FOR PREPARING ELECTRON DEFICIENT OLEFINS

-

Paragraph 0065, (2018/07/29)

This invention relates to a process for preparing electron deficient olefins, such as 2-cyanoacrylates, using an acid catalyzed two-step process including a transesterification reaction followed by a Knoevenagel condensation reaction.

Method for synthesizing cyanoacrylate

-

Paragraph 0040; 0041, (2016/10/10)

The invention discloses a method for synthesizing cyanoacrylate. The method comprises steps as follows: cyanoacetic ester and dialkoxymethane are taken as raw materials and have a condensation reaction under the catalytic action of a catalyst, and a reaction mixture of a cyanoacrylate containing oligomer and byproduct alcohol is obtained; the byproduct alcohol and unreacted dialkoxymethane are separated, a stabilizer is added to the remaining reaction mixture, cracking distillation under the reduced pressure is performed, and a cyanoacrylate crude product is obtained; the crude product is purified, and a finished product, namely, cyanoacrylate is obtained. Solid paraformaldehyde is not used any more, the difficulty of solid feeding is reduced, a dehydration step is not required, a dehydrating agent is not required to be used, defects of a condensation polymerization process using solid paraformaldehyde and using a solvent for continuous dehydration in conventional cyanoacrylate synthesis are avoided, the reaction process is easier to control, the process is simple, the operability is high, the method is economical and reasonable, discharge of three wastes and pollution to the environment are greatly reduced, and the method has good social benefits.

Process for preparing 1,1-disubstituted ethylenic monomers

-

Paragraph 0092, (2015/11/16)

The present invention relates to a process for preparing 1,1-disubstituted ethylene monomers having general formula (I) from a compound of general formula (II) and an active methylene compound of general formula (III) using a catalytic amount of an ammonium or iminium salt in homogeneous phase or supported on a solid substrate. Said process allows the direct synthesis of the monomers and finds application in the preparation of a wide variety of monomers. The products obtained are reactive monomers of high purity which find application in the field of fast curing adhesives.

IMINIUM SALTS AND METHODS OF PREPARING ELECTRON DEFICIENT OLEFINS USING SUCH NOVEL IMINIUM SALTS

-

Page/Page column 35, (2008/12/05)

This invention relates to novel iminium salts, which may be in the form of ionic liquids, and a process for producing electron deficient olefins, such as 2-cyanoacrylates, using such an iminium salt, for instance in the form of an ionic liquid.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 6606-65-1